These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. miRNA expression profiling of 'noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas. Borrelli N; Denaro M; Ugolini C; Poma AM; Miccoli M; Vitti P; Miccoli P; Basolo F Mod Pathol; 2017 Jan; 30(1):39-51. PubMed ID: 27586203 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues. Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771 [TBL] [Abstract][Full Text] [Related]
6. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features. Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Vriens MR; Weng J; Suh I; Huynh N; Guerrero MA; Shen WT; Duh QY; Clark OH; Kebebew E Cancer; 2012 Jul; 118(13):3426-32. PubMed ID: 22006248 [TBL] [Abstract][Full Text] [Related]
8. Expression of micro-ribonucleic acids in thyroid nodules and serum to discriminate between follicular adenoma and cancer in patients with a fine needle aspiration biopsy classified as suspicious for follicular neoplasm: A preliminary study. Świrta JS; Wątor G; Seweryn M; Kapusta P; Barczyński M; Wołkow P Adv Clin Exp Med; 2023 Sep; 32(9):997-1007. PubMed ID: 36897102 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration. Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346 [TBL] [Abstract][Full Text] [Related]
11. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples. Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927 [TBL] [Abstract][Full Text] [Related]
14. A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples. Denning KM; Smyth PC; Cahill SF; Finn SP; Conlon E; Li J; Flavin RJ; Aherne ST; Guenther SM; Ferlinz A; O'Leary JJ; Sheils OM Mod Pathol; 2007 Oct; 20(10):1095-102. PubMed ID: 17660800 [TBL] [Abstract][Full Text] [Related]
15. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390 [TBL] [Abstract][Full Text] [Related]
16. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma. Qiu Z; Li H; Wang J; Sun C Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma. Igci YZ; Arslan A; Akarsu E; Erkilic S; Igci M; Oztuzcu S; Cengiz B; Gogebakan B; Cakmak EA; Demiryurek AT Endocr Pathol; 2011 Jun; 22(2):86-96. PubMed ID: 21509594 [TBL] [Abstract][Full Text] [Related]
18. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules. Siddiqui MT; Greene KL; Clark DP; Xydas S; Udelsman R; Smallridge RC; Zeiger MA; Saji M Diagn Mol Pathol; 2001 Jun; 10(2):123-9. PubMed ID: 11385322 [TBL] [Abstract][Full Text] [Related]
19. The diagnostic and prognostic role of miR-146b-5p in differentiated thyroid carcinomas. Ferraz C; Cunha GB; de Oliveira MMB; Tenório LR; Cury AN; Padovani RDP; Ward LS Front Endocrinol (Lausanne); 2024; 15():1390743. PubMed ID: 39036050 [TBL] [Abstract][Full Text] [Related]
20. Analytical validity of a microRNA-based assay for diagnosing indeterminate thyroid FNA smears from routinely prepared cytology slides. Benjamin H; Schnitzer-Perlman T; Shtabsky A; VandenBussche CJ; Ali SZ; Kolar Z; Pagni F; ; Bar D; Meiri E Cancer Cytopathol; 2016 Oct; 124(10):711-721. PubMed ID: 27223344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]